{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:35:33Z","timestamp":1788622533308,"version":"build-2803163510"},"reference-count":28,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical and Experimental Hypertension"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.3109\/10641963.2012.690472","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T14:29:28Z","timestamp":1339165768000},"page":"87-94","source":"Crossref","is-referenced-by-count":4,"title":["Administration of Angiotensin Receptor II Blockade Improves Vascular Function, Urinary Albumin Excretion, and Left Ventricular Hypertrophy in Low-Risk Essential Hypertensive Patients Receiving Antihypertensive Treatment with Calcium Channel Blockers"],"prefix":"10.1080","volume":"35","author":[{"given":"Yoshihiko","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Medicine, Tokyo Women\u2019s Medical University, Medical Center East","place":["Japan"]},{"name":"Department of Medicine, Tokyo Women\u2019s Medical University, Medical Center East, Nippori Clinic","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tokyo Women\u2019s Medical University, Medical Center East","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mitsuhashi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tokyo Women\u2019s Medical University, Medical Center East","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanobu","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tokyo Women\u2019s Medical University, Medical Center East","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tokyo Women\u2019s Medical University, Medical Center East","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tokyo Women\u2019s Medical University, Medical Center East","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,6,8]]},"reference":[{"key":"e_1_3_1_2_1","first-page":"234","article-title":"Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension \u2013 a prospective, randomized, double-blind comparison of Telmisartan with metoprolol over a period of six months \u2013 rationale and study design","volume":"4","author":"Friedrich MG","year":"2003","unstructured":"Friedrich MG, Dahlf B, Sechtem U, Unger T, Knecht M, Dietz R.: for the TELMAR Investigators. Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension \u2013 a prospective, randomized, double-blind comparison of Telmisartan with metoprolol over a period of six months \u2013 rationale and study design. JRAAS 2003; 4:234\u2013243.","journal-title":"JRAAS"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000186829.56372.04"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000803600529"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.34"},{"key":"e_1_3_1_6_1","first-page":"849","article-title":"Proposed guidelines for the clinical evaluation of antihypertensive drugs","volume":"10","author":"Murakami M","year":"1979","unstructured":"Murakami M, Ikeda M, Kaneko Y, . Proposed guidelines for the clinical evaluation of antihypertensive drugs. Drug res 1979; 10:849\u2013864 (in Japanese).","journal-title":"Drug res"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1992.tb02812.x"},{"key":"e_1_3_1_8_1","first-page":"423","article-title":"Self-monitoring of blood pressure at home and depressor effect of perindopril on the resistant morning hypertension in the elderly hyertensives (special investigation of Coversyl tablets)","volume":"25","author":"Otsuka K","year":"2004","unstructured":"Otsuka K, Tano T, Yatagai S, . Self-monitoring of blood pressure at home and depressor effect of perindopril on the resistant morning hypertension in the elderly hyertensives (special investigation of Coversyl tablets). Thrapeutic res 2004; 25:423\u2013430. (in Japanese)","journal-title":"Thrapeutic res"},{"key":"e_1_3_1_9_1","first-page":"537","article-title":"Evidence-based practice guideline for the treatment of CKD","volume":"3","author":"Japanese Society of Nephrology","year":"2009","unstructured":"Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin exp nephrol 2009; 3:537\u2013566.","journal-title":"Clin exp nephrol"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.887"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.6.1072"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.55.4.613"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.7.987"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.03.009"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.02.022"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000060460.52916.D6"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.26.3.485"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1081\/CEH-200067668"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641963.2011.583970"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.13.101"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S13492"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01219-X"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.4.421"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000031732.78052.81"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006040377"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.21"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.8.2007"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1081\/CEH-100108720"}],"container-title":["Clinical and Experimental Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10641963.2012.690472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:47:43Z","timestamp":1770943663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10641963.2012.690472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.3109\/10641963.2012.690472"],"URL":"https:\/\/doi.org\/10.3109\/10641963.2012.690472","relation":{},"ISSN":["1064-1963","1525-6006"],"issn-type":[{"value":"1064-1963","type":"print"},{"value":"1525-6006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,8]]}}}